| 中文名 | 5-羟基尿苷 |
|---|---|
| 英文名 | 5-hydroxyuridine |
| 中文别名 |
5-羟基尿苷, 异巴比妥尿苷
1-((2R,3R,4S,5R)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-基)-5-羟基嘧啶-2,4(1H,3H)-二酮 异巴比妥尿苷 |
| 英文别名 |
Isobbituridine
5-Hydroxyuridine, isobbituri dine,RNA-modified nucleoside ho5U, anticancer agent 5-HYDROXYURIDINE 5-Hydroxy-uridin 5-Hydroxy-uracil-ribotid Uridine, 5-hydroxy 5-Hydroxyuridine, isobbituridine 1-[(2R,3R,4S,5R)-3,4-DIHYDROXY-5-(HYDROXYMETHYL)OXOLAN-2-YL]-5-HYDROXY-3H-PYRIMIDINE-2,4-DIONE 1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-hydroxypyrimidine-2,4(1H,3H)-dione 1-beta-D-Ribofuranosylisobbituric acid Uridine,5-hydroxy 5-hydroxy-uridine 1-(β-D-Ribofuranosyl)-5-hydroxypyrimidine-2,4(1H,3H)-dione 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methylol-tetrahydrofuran-2-yl]-5-hydroxy-pyrimidine-2,4-quinone 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-hydroxy-pyrimidine-2,4-dione 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-hydroxypyrimidine-2,4-dione |
| 描述 | 5-羟基尿苷(OHUrd)是嘌呤核苷类似物。嘌呤核苷类似物具有广泛的抗肿瘤活性,靶向惰性淋巴系统恶性肿瘤。这一过程中的抗癌机制依赖于抑制DNA合成、诱导细胞凋亡等[1]。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 密度 | 1.8±0.1 g/cm3 |
|---|---|
| 分子式 | C9H12N2O7 |
| 分子量 | 260.20 |
| 精确质量 | 260.064453 |
| PSA | 145.01000 |
| LogP | -1.51 |
| 折射率 | 1.698 |
| 储存条件 | 2-8°C |
|
~%
957-77-7
详细
|
| 文献:Acta Chemica Scandinavica, Series B: Organic Chemistry and Biochemistry, , vol. 40, # 9 p. 768 - 775 |